interferon beta-1a

FDA Drug Profile — REBIF, Rebif, AVONEX

interferon beta-1a is listed in the FDA National Drug Code directory with 6 NDC codes, marketed under brand names including REBIF, Rebif, AVONEX. Available dosage forms: liquid, injection, solution, kit.

Drug details

Generic Name
interferon beta-1a
Brand Names
REBIF, Rebif, AVONEX
Application Number
BLA103780
Sponsor
Biogen Inc.
NDC Codes
6
Dosage Forms
LIQUID, INJECTION, SOLUTION, KIT
Routes
SUBCUTANEOUS, INTRAMUSCULAR
Active Ingredients
INTERFERON BETA-1A

Indications and Usage

1 INDICATIONS AND USAGE AVONEX is indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults. AVONEX is for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults. ( 1 )

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.